Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.
Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, Bredius RG, Egberts AC, Bierings M, Kletzel M, Shaw PJ, Nath CE, Hempel G, Ansari M, Krajinovic M, Théorêt Y, Duval M, Keizer RJ, Bittencourt H, Hassan M, Güngör T, Wynn RF, Veys P, Cuvelier GD, Marktel S, Chiesa R, Cowan MJ, Slatter MA, Stricherz MK, Jennissen C, Long-Boyle JR, Boelens JJ. Bartelink IH, et al. Among authors: hassan m. Lancet Haematol. 2016 Nov;3(11):e526-e536. doi: 10.1016/S2352-3026(16)30114-4. Epub 2016 Oct 13. Lancet Haematol. 2016. PMID: 27746112 Free PMC article.
Busulfan bioavailability.
Hassan M, Ljungman P, Bolme P, Ringdén O, Syrůcková Z, Békàssy A, Starý J, Wallin I, Kållberg N. Hassan M, et al. Blood. 1994 Oct 1;84(7):2144-50. Blood. 1994. PMID: 7919328 Free article.
Pharmacokinetics of liposomal busulphan in man.
Hassan Z, Ljungman P, Ringdén O, Winiarski J, Nilsson C, Aschan J, Whitley HR, Hassan M. Hassan Z, et al. Among authors: hassan m. Bone Marrow Transplant. 2001 Mar;27(5):479-85. doi: 10.1038/sj.bmt.1702823. Bone Marrow Transplant. 2001. PMID: 11313681 Clinical Trial.
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Hassan M, Nilsson C, Hassan Z, Gungor T, Aschan J, Winiarski J, Hentschke P, Ringdén O, Eber S, Seger R, Ljungman P. Hassan M, et al. Among authors: hassan z. Bone Marrow Transplant. 2002 Dec;30(12):833-41. doi: 10.1038/sj.bmt.1703739. Bone Marrow Transplant. 2002. PMID: 12476274 Clinical Trial.
6,586 results